| SpectraBase Spectrum ID |
DlzL92P7vU0 |
| Name |
1,4-Di-(1phenylprop-2-yl)piperazine |
| Classification |
Amphetamine analog designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
322.240898974 u |
| Formula |
C22H30N2 |
| InChI |
InChI=1S/C22H30N2/c1-19(17-21-9-5-3-6-10-21)23-13-15-24(16-14-23)20(2)18-22-11-7-4-8-12-22/h3-12,19-20H,13-18H2,1-2H3 |
| InChIKey |
VIYHGODXJCNFCQ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
322.496 g/mol |
| Nominal Mass |
322 u |
| Quality |
997 |
| Retention Index |
2453 |
| SMILES |
C(N1CCN(C(CC=2C=CC=CC2)C)CC1)(CC=1C=CC=CC1)C |
| SPLASH |
splash10-000x-9340000000-bb5f8e5ce74b16deefbf |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(1phenylprop-2-yl)
1-(1-Phenylprop-2-yl)-4-(1-phenylprop-2-yl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_009002 |
